Among the many responsibilities assigned to medical science liaisons (MSLs) is facilitating company collaboration with thought leaders on clinical trial work. According to MSL teams surveyed by Cutting Edge Information, seemingly little time and ostensibly minor goals are assigned to this activity. But when considering the many tasks MSLs already perform and their headcount per region, even a minor focus on facilitating investigator-initiated trials (IITs) and other study types may be more than enough to meet company goals. Todd Middleton at Cutting Edge Information discusses further.
[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/04/Clinical-and-investigator-initiated-trials-effect.pdf” width=”100%” height=”900px” style=”border:0;”]